Summary:
If you are a smoker and are part of the adult population who suffer from a mental illness or disorder, you may be interested in a research study which is being conducted to evaluate the use of the drugs varenicline and bupropion as aids to smoking cessation. To help you quit, smoking cessation counseling sessions will be included as part of the study.
Qualified Participants Must:
•
Between18 and 75 years of age
•
Current smokers who smoke ten or more cigarettes per day
Motivated to quit smoking
Qualified Participants May Receive:
Qualified individuals will receive varenicline, bupropion, tansdermal nicotine patch, or placebo (inactive substance that looks like the study drug). After 12 weeks of treatment, there is an additional 12 week non-treatment follow-up phase. Smoking cessation counseling and all study related medical care will be provided at no cost. You may also be reimbursed for time and travel.